drug
Xgeva
Marketedupdated 3mo agoby $AMGN AMGEN INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8all catalysts(0)
nothing on the calendar yet
Trials studying Xgeva
- phase2Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- phase2Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- phase2Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
- phase2Romosozumab/Denosumab Study for Premenopausal IOP
- phase2A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
- phase2Denosumab for Smoldering Multiple Myeloma
- phase2A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
- phase3Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
News(1)
- Dr Silbermann on Clinical Trial Design Considerations in Multiple MyelomaRebecca Silbermann, MD, MMS, outlines key trial design considerations in multiple myeloma, including supportive care measures and end point selection.onclive · 3mo ago
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that